GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes mellitus. Each tablet contains Teneligliptin 20 mg + Metformin Hydrochloride IP 1000 mg. Teneligliptin helps improve insulin secretion and reduce glucagon levels, while Metformin enhances insulin sensitivity and decreases hepatic glucose production. This combination supports effective glycemic control, helps reduce HbA1c levels, and is widely used in patients requiring stronger and sustained blood sugar management.
Related products
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLIPDIP M
GLIPDIP M is used for effective management of type 2 diabetes mellitus. Each tablet contains...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
DUET ACT 2 FORTE
DUET ACT 2 FORTE Tablet is a combination medicine used for effective management of type...
DUET ACT 2
DUET ACT 2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for better blood...
DAPAGLIDE 10
COMPOSITION : Dapagliflozin 10 mg
CARBOSTOP 50
CARBOSTOP 50 Tablet is a combination medicine used for managing type 2 diabetes effectively. It...
